Related Experiment Video

Updated: Aug 12, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Inhibition of cancer cell growth by internalized immuno-histone conjugates

E M Rakowicz-Szulczynska1, D G McIntosh, P Lewis

  • 1Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha 68198-3255, USA.

Cancer Biotherapy & Radiopharmaceuticals
|February 1, 1996
PubMed

Insights

Monoclonal antibodies (MAbs) conjugated with histone and labeled with radioactive iodine (125I) effectively target breast and cervical cancer cells. These MAb-histone complexes inhibit cancer cell proliferation and RNA synthesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioconjugation

Background:

  • Monoclonal antibodies (MAbs) are increasingly explored for targeted cancer therapies.
  • Internalization and nuclear translocation of MAbs offer potential for delivering therapeutic payloads.
  • Histone conjugation can facilitate cellular uptake and nuclear localization of antibodies.

Purpose of the Study:

  • To develop and characterize MAb-histone complexes for targeted cancer therapy.
  • To investigate the cellular uptake, localization, and stability of these complexes.
  • To evaluate the therapeutic potential of MAb-histone complexes in inhibiting cancer cell growth.

Main Methods:

  • Conjugation of MAb NS 88 with histone and labeling with 125I.
  • Internalization and localization studies in breast and cervical cancer cells.
  • Electrophoretic analysis to confirm complex integrity.
  • Assessment of RNA synthesis and cell proliferation inhibition.

Main Results:

  • 125I-MAb-histone complexes were internalized and localized in the cytoplasm and chromatin of cancer cells.
  • Nicotine treatment stabilized the complexes, prolonging their presence intracellularly.
  • MAb-histone complexes, but not MAb alone, significantly inhibited RNA synthesis and proliferation.
  • Complexes maintained their molecular weight within the cells, indicating stability.

Conclusions:

  • Internalized MAb-histone complexes show promise as vehicles for delivering protein inhibitors.
  • This approach offers a novel strategy for targeting cancer cell transcription and replication.
  • Further research into MAb-based drug delivery systems for cancer is warranted.

More Related Videos

Assays for Validating Histone Acetyltransferase Inhibitors09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.